VT
RDY icon

Vise Technologies’s Dr. Reddy's Laboratories RDY Stock Holding History

Vise Technologies’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
48,504
+24,901
+105% +$336K 0.01% 969
2026
Q1 		$331K Hold
23,603
– – 0.01% 1094
2025
Q4 		$331K Buy
23,603
+3,529
+18% +$49.5K 0.01% 1100
2025
Q3 		$281K Buy
20,074
+1,128
+6% +$16.2K 0.01% 929
2025
Q2 		$285K Buy
+18,946
New +$271K 0.01% 856

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vise Technologies's RDY Position: Q2 2026 in Review

Vise Technologies increased its Dr. Reddy's Laboratories (RDY) stake by 105% in Q2 2026, buying an estimated $336K and bringing the position to 48,504 shares worth $703K. The position accounts for 0.01% of the portfolio, ranked #969.

Vise Technologies first reported a position in RDY in Q2 2025 and has held it in 5 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Vise Technologies held 48,504 shares of Dr. Reddy's Laboratories worth $703K as of Q2 2026.
  • Vise Technologies bought 24,901 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $336K.
  • Dr. Reddy's Laboratories made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #969 holding.
  • Vise Technologies first reported a position in Dr. Reddy's Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.